Nascent Biotech, Inc. Developing Therapy with Indications for COVID-19
09 avr. 2020 08h30 HE
|
Small Caps Daily
NEW YORK, NY, April 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nascent Biotech, Inc. (OTCQB: NBIO) (the "Company"), a biotechnology company developing proprietary human Monoclonal Antibodies...